Molecular Diagnostic Approaches and Their Clinical Utility

Aug 13, 2017 by in ONCOLOGY Comments Off on Molecular Diagnostic Approaches and Their Clinical Utility

  Implied risk of malignancy according to TBSRTC (%) [1] Estimated risk based on reported studies (%) [5] Atypia of unknown significance/follicular lesion of unknown significance (AUS/FLUS) 5–15% 6–48% Follicular…

read more

The Rising Incidence of Thyroid Cancer: Contributions from Healthcare Practice and Biologic Risk Factors

Aug 13, 2017 by in ONCOLOGY Comments Off on The Rising Incidence of Thyroid Cancer: Contributions from Healthcare Practice and Biologic Risk Factors

Fig. 1.1 Incidence by histology of thyroid cancer and mortality of thyroid cancer, 1975–2011. Data are from the Surveillance, Epidemiology, and End Results (SEER) program (www.​seer.​cancer.​gov) SEER*Stat Database: Incidence—SEER 9…

read more

Molecular Genetics of Thyroid Cancer

Aug 13, 2017 by in ONCOLOGY Comments Off on Molecular Genetics of Thyroid Cancer

Tumor Genes Frequency Citations PTC BRAF 40–50% [2, 4–8]  RET/PTC 10–20% [2, 9, 10]  RAS 10–20% [11–15]  TRK 5–13% [16]  TERT 9% [2]  EIF1AX 2% [2] FTC RAS 20–50% [13,…

read more

Clinical Presentation and Diagnosis of Papillary Thyroid Cancer

Aug 13, 2017 by in ONCOLOGY Comments Off on Clinical Presentation and Diagnosis of Papillary Thyroid Cancer

© The Author(s) 2017Anne T. Mancino and Lawrence T. Kim (eds.)Management of Differentiated Thyroid Cancer10.1007/978-3-319-54493-9_6 6. Clinical Presentation and Diagnosis of Papillary Thyroid Cancer Cord Sturgeon1  , Dina Elaraj1 and Anthony Yang1 (1) Department of Surgery, Section of Endocrine…

read more

Evaluation of a Thyroid Nodule

Aug 13, 2017 by in ONCOLOGY Comments Off on Evaluation of a Thyroid Nodule

  Sensitivity Specificity Ultrasound [29] 63–87 80–94% Elastography [30, 31] 92% 90% MRI [27] 90% 95% CT/PET [28, 32] 88–92% 64–87% In terms of correlation between physical exam findings and…

read more

Malignant Changes

Aug 13, 2017 by in ONCOLOGY Comments Off on Malignant Changes

and Christian Waldherr1 (1) Bern, Switzerland   6.1 Malignant Changes: Ductal Carcinoma in Situ (DCIS) 6.1.1 Case 1 General Information/Clinical Issues Patient was a 62-year-old female. cT0 N0, previous history of…

read more
Get Clinical Tree app for offline access